Related by context. All words. (Click for frequent words.) 74 Unfractionated Heparin 70 molecular weight heparins 70 unfractionated heparin UFH 69 Enoxaparin 68 Combination Therapy 68 Cilostazol 68 Low Dose 68 Disease Progression 67 Bone Mineral Density 67 Vitamin D Linked 67 Viral Load 67 Bivalirudin 67 Fracture Risk 67 Monotherapy 67 Adefovir 67 Fondaparinux 67 Nilotinib 67 Pioglitazone 66 Molecular Weight Heparins 66 dose atorvastatin 66 Posaconazole 66 LDL Cholesterol 66 Tolerability 66 Valsartan 66 Pegylated Liposomal Doxorubicin 66 Lenalidomide 66 Efficacious 66 Birth Weight 66 Molecular Weight 66 Double Blind Randomized 66 Breast Cancer Recurrence 66 Peginterferon 66 Adjuvant Therapy 66 Aliskiren 65 Patients Treated 65 Prolongs Survival 65 Cardiovascular Events 65 Elderly Patients 65 Acute Ischemic Stroke 65 dalteparin 65 Inhaled Corticosteroids 65 dose cytarabine 65 Fixed Dose 65 Cholesterol Levels 65 Abciximab 65 Appears Safe 65 Dasatinib 65 Capecitabine 65 Thiazolidinediones 65 Protease Inhibitors 65 Tiotropium 65 Vitamin D Levels 65 Fibrates 65 Antipsychotic 65 Bare Metal Stents 64 Meets Primary Endpoint 64 antiplatelet agent 64 Randomized Comparison 64 grade glioma 64 Clinical Outcome 64 Peginterferon Alfa 2a 64 Erlotinib 64 Cardiotoxicity 64 C Reactive Protein 64 dose Iluvien 64 Kidney Function 64 Single Dose 64 Infected Patients 64 ACE Inhibitors 64 Parathyroid Hormone 64 Patients Undergoing 64 Patients Treated With 64 LMWH 64 Previously Untreated 64 Regimens 64 Fidaxomicin 64 Prophylactic Treatment 64 Blood Pressure Drug 64 Metastatic Colorectal Cancer 64 Platelet Counts 64 Glucose Metabolism 64 Septic Shock 64 Adjuvant Treatment 64 Hypercholesterolemia 64 angiotensin converting enzyme inhibitors 64 mycophenolate mofetil 63 Randomized Evaluation 63 Insulin Glargine 63 Antitumor Activity 63 ritonavir boosted 63 Is Well Tolerated 63 Endarterectomy 63 Immune Responses 63 NAVISTAR R 63 Protease Inhibitor 63 weight heparin LMWH 63 Pooled Analysis 63 Metastatic Prostate Cancer 63 Losartan 63 Glatiramer Acetate 63 Demonstrates Efficacy 63 Clopidogrel 63 Hemoglobin Levels 63 Venlafaxine 63 See CLINICAL PHARMACOLOGY 63 Relapsing Remitting Multiple Sclerosis 63 Well Tolerated 63 Pediatric Patients 63 Clinical Trial Results 63 Treating Chronic 63 Patency 63 Teriparatide 63 Fulvestrant 63 platelet reactivity 63 Levels Linked 63 Neoadjuvant 63 Unresectable 63 Statistically Significant 63 Improves Survival 63 Fludarabine 63 APTIVUS 63 Epoetin Alfa 63 fluvastatin 63 Rheumatoid Arthritis Patients 63 Corticosteroid 63 Benazepril 63 Ranolazine 63 Long Term Efficacy 63 Bevacizumab 63 Secondary Hyperparathyroidism 63 lipid elevations 63 Patients Receiving 63 posaconazole 63 Lopinavir 63 Oral Fingolimod 63 Fungal Infections 63 Treated Patients 63 Carotid Stenting 63 Helicobacter pylori eradication 63 Statin Therapy 63 Controlled Trial 62 serum phosphate 62 Telbivudine 62 Knee Osteoarthritis 62 abacavir lamivudine 62 Nucleoside 62 Overactive Bladder 62 Anthracycline 62 grade gliomas 62 Radiation Dose 62 Clinical Efficacy 62 Chronic Hepatitis B 62 Bisphosphonate 62 Pharmacodynamics 62 dexamethasone Decadron 62 Achieves Primary Endpoint 62 Metastatic Renal Cell Carcinoma 62 Renal Cell Carcinoma 62 Cardiovascular Outcomes 62 Receptor Antagonist 62 Ischemic 62 Bioavailability 62 TMP SMX 62 Demonstrated Significant 62 Hormone Therapy 62 Prospective Randomized Trial 62 Obese Patients 62 Postmenopausal Women 62 Anti Tumor Activity 62 aspirin clopidogrel 62 Chemoradiation 62 Randomized Clinical Trial 62 Controlled Study 62 Celecoxib 62 Hepatitis C Genotype 62 Intravitreal 62 Chronic Hepatitis C 62 Desvenlafaxine Succinate 62 Cytotoxic 62 Allogeneic 62 Anticoagulants 62 Pivotal Trial 62 Drug Shows Promise 62 Orally Active 62 Long Term Outcomes 62 Improves Outcomes 62 Post Operative 62 β blockers 62 Recurrent Stroke 62 Interferon alfa 62 Investigational Compound 62 Recombinant Human 62 Combination Treatment 62 Survival Rates 62 tirofiban 62 Relapsing Multiple Sclerosis 62 Bare Metal Stent 62 Blood Clot Risk 62 Pegylated Interferon 62 Survival Benefit 62 Fluconazole 62 Radiofrequency Ablation 62 Anticoagulant 62 Ezetimibe 62 Zoledronic Acid 62 Glycemic Control 62 Lung Cancer Survival 62 Hormone Receptor Positive 62 Melphalan 62 Diabetic Patients 62 Beta Blocker 62 Localized Prostate Cancer 62 protease inhibitors PIs 62 Trastuzumab 62 Skeletal Muscle 62 Sustained Virologic Response 62 Lacosamide 62 Granulocyte Colony Stimulating Factor 62 paroxetine Paxil 62 Immunosuppression 62 Uric Acid 62 fosamprenavir 62 Adjunctive 62 Adjuvant Chemotherapy 62 Prospective Randomized 62 Respiratory Virus 61 COPD Exacerbations 61 Fluticasone 61 Lipid Levels 61 Medoxomil 61 Pharmacokinetic Study 61 sotalol 61 Non Inferiority 61 Hormone Refractory Prostate Cancer 61 baseline LDH 61 Mitoxantrone 61 Hemodialysis Patients 61 Antiplatelet Therapy 61 Hyperlipidemia 61 Osteoporosis Drugs 61 Thromboembolism 61 Cardiovascular Disease Risk 61 Decitabine 61 Pin Count 61 Vildagliptin 61 Demonstrates Significant 61 Advanced Melanoma 61 Breast Tumors 61 Study Evaluating 61 Beta Blockers 61 Corticosteroids 61 Vitro Activity 61 Apolipoprotein B 61 Complicated Skin 61 Severe Sepsis 61 hypercholesterolaemia 61 Plus Ribavirin 61 Shows Efficacy 61 5 Fluorouracil 61 Showed Significant 61 Hypertensive Patients 61 nonnucleoside reverse transcriptase inhibitors 61 Darunavir 61 tigecycline 61 HMG CoA reductase inhibitors 61 Interferon beta 1b 61 neutrophil counts 61 Antihypertensive 61 Restenosis 61 Saquinavir 61 Demonstrates Positive 61 AZT zidovudine Retrovir 61 tiuxetan 61 Cytarabine 61 Antiviral Activity 61 Cyclosporine 61 Oxaliplatin 61 Previously Treated 61 Raltegravir 61 Juvenile Idiopathic Arthritis 61 Radical Prostatectomy 61 Hepatocellular Carcinoma 61 paricalcitol 61 Kidney Transplant Patients 61 Renal Function 61 Prophylaxis 61 Dapagliflozin 61 FDA Approvals 61 Left Ventricular 61 FASLODEX 61 Phase III Clinical Trial 61 Preterm Delivery 61 pioglitazone HCl 61 Treatment Naive HIV 61 Oral Mucositis 61 Novel Inhibitor 61 Interferon Beta 61 SPIRIVA ® 61 Advanced Prostate Cancer 61 Anti TNF 61 Interferon Alfa 61 chlorthalidone 61 nephrotoxicity 61 Lubiprostone 61 Cholesterol Lowering Drug 61 Naive Patients 61 Darbepoetin Alfa 61 Enalapril 61 Viral Suppression 61 Zileuton 61 Tyrosine Kinase Inhibitor 61 Study Showed 61 Anti Tumor 61 BENICAR HCT 61 Percutaneous Coronary Intervention 61 Daptomycin 61 Degarelix 61 Atypical Hemolytic Uremic Syndrome 61 serum LDL cholesterol 61 Somatostatin 61 paclitaxel eluting stents 61 IIIa inhibitor 61 Urinary Incontinence 61 serum creatinine levels 61 Baynes dunked 61 pyrazinamide 61 Improved Survival 61 Combo Therapy 61 Cethromycin 61 Biphasic 61 Endothelial Function 61 hyperphenylalaninemia HPA due 61 Resistant Hypertension 61 relapsed MM 61 Tumor Growth 61 lumbar spine BMD 61 Glucose Levels 61 grade cervical intraepithelial 61 Alendronate 61 Relapsed Multiple Myeloma 61 Nebulized 61 Quantitation 61 Hepatitis B Virus 61 Stent Thrombosis 61 Lamotrigine 61 Pulmonary Arterial Hypertension 61 Low Density Lipoprotein Cholesterol 61 Bosutinib 61 Venous Thromboembolism 61 Refractory Hodgkin Lymphoma 61 Tumor Response 61 Breast Cancers 61 dose oral contraceptive 61 ximelagatran 61 Cytotoxicity 61 ACE Inhibitor 61 secondary hyperparathyroidism 60 Rotavirus Vaccine 60 Rivaroxaban 60 HDL Cholesterol 60 Pegylated 60 Ramipril 60 ritonavir boosted lopinavir 60 corticosteroid dexamethasone 60 Randomized Double Blind 60 clodronate 60 Dose Escalation 60 abacavir Ziagen 60 Perindopril 60 Significantly Reduced 60 Premenopausal Women 60 Blood Cholesterol 60 Hemolysis 60 Endovascular Treatment 60 idraparinux 60 Mg Usa 60 HCV Genotype 60 Thrombus 60 Novel Mechanism 60 Moxifloxacin 60 Percutaneous Tibial Nerve Stimulation 60 Brain Metastases 60 Dual Antiplatelet Therapy 60 Improve Survival 60 Heart Failure Patients 60 sorafenib Nexavar 60 Data Suggest 60 Azacitidine 60 Randomized Placebo Controlled Trial 60 Bisphosphonates 60 Demonstrates Potent 60 coadministration 60 pretest probability 60 Therapy Reduces 60 Randomized Study 60 Bosentan 60 Natalizumab 60 Erectile Dysfunction Drug 60 Inflammatory Markers 60 Treatment Naive Patients 60 dose dexamethasone 60 grade cervical lesions 60 Rheumatoid Arthritis Drug 60 Interferon Alpha 60 Randomised 60 Contrast Agents 60 Treatment Regimen 60 Catheter Ablation 60 Bronchodilator 60 BARACLUDE ® 60 Methylnaltrexone 60 Hepatic Encephalopathy 60 HER2 expression 60 Phase 2a Clinical Trial 60 Tipranavir 60 pegfilgrastim 60 Non inferiority 60 Myocardial Perfusion Imaging 60 Virologic 60 Aortic Stenosis 60 Dendritic Cells 60 Inflammatory Pain 60 von Willebrand Factor 60 Cyclophosphamide 60 Lung Cancer Risk 60 Receptor Antagonists 60 MEVACOR 60 Cyclooxygenase 2 60 salmeterol fluticasone 60 imipenem 60 Acute Myocardial Infarction 60 Clostridium difficile Infection 60 Mycophenolate Mofetil 60 Platelet Inhibition 60 Cinacalcet 60 BAL# [002] 60 Guidance Range 60 angiotensin receptor blocker ARB 60 Subtypes 60 Placebo Controlled Trial 60 Exacerbation 60 tenofovir Viread 60 Proven Effective 60 HER2 overexpression 60 pimecrolimus cream 60 Bortezomib 60 Randomized Controlled Trial 60 apolipoprotein B 60 Hip Fractures 60 Chronic Heart Failure 60 Antiplatelet 60 Meta Analysis 60 cinacalcet 60 Pafuramidine 60 Significantly Reduces 60 Placebo Controlled Study 60 Dabigatran etexilate 60 Gastric Cancer 60 Investigational Agent 60 Glucose Control 60 Dyslipidemia 60 Fluorouracil 60 IOP lowering 60 Phase 2b Study 60 Epivir 60 lanthanum carbonate 60 Gene Mutation 60 JAK Inhibitor 60 Fibrinogen 60 macrolide antibiotic 60 serotonin norepinephrine reuptake inhibitor 60 ARIXTRA 60 nucleotide analog 60 invasive candidiasis 60 pharmacodynamic parameters 60 EGFR TKI 60 Breast Cancer Risk 60 caspofungin 60 Dose Response 60 Demonstrates Statistically Significant 60 efavirenz EFV 60 Insulins 60 Mg Uk 60 Atopic Dermatitis 60 Noxafil 60 Pivotal Phase 60 Calcium Intake 60 Induces 60 Bone Metastases 60 Insulin Secretion 60 Omacetaxine 60 epoetin alpha 60 APTIVUS r 60 Vaginal Gel 60 Intraocular Pressure 60 Testosterone Levels 60 Irinotecan 60 Replacement Therapy 60 budesonide formoterol 60 Antiviral Therapy 60 fosbretabulin 60 Autologous Stem Cell Transplantation 60 Significantly Improved 60 adenoma recurrence 60 aldosterone antagonists 60 CANCIDAS 59 Endothelial 59 Radiofrequency Ablation RFA 59 eluting stent 59 Transdermal Patch 59 grade squamous intraepithelial 59 Volume Terminals MIDS 59 Investigational Drug 59 NDA Submission 59 Pemetrexed 59 Breast Density 59 Estrogen Receptor 59 induce orthostatic hypotension 59 Study Demonstrates 59 Watchful Waiting 59 Diuretic 59 PPAR gamma agonists 59 dose ritonavir 59 Gene Variant 59 nelfinavir 59 Adjunctive Therapy 59 Rates Remain 59 Prostate Cancer Recurrence 59 Multicenter Trial 59 Anticoagulation 59 Novel Oral 59 STRIDE PD 59 Sirolimus Eluting Stent 59 cilostazol 59 Demonstrates Potential 59 Montelukast 59 TREDAPTIVE 59 antibiotic azithromycin 59 PEGINTRON TM 59 Androgen Receptor 59 Levofloxacin 59 Vidaza azacitidine 59 Tumor Cell 59 Newly Diagnosed Multiple Myeloma 59 Castration Resistant Prostate Cancer 59 Antitumor 59 Hepatitis C Patients 59 nicardipine 59 Telithromycin 59 Androgen Deprivation Therapy 59 dose cyclophosphamide 59 Intravesical 59 octreotide LAR 59 xanthine oxidase inhibitor 59 Eculizumab 59 tocilizumab 59 sertraline Zoloft 59 MULTAQ 59 Initiate Clinical Trial 59 Catheter Related Bloodstream Infections 59 Tekamlo 59 Venous Thrombosis 59 Organ Rejection 59 Lung Tumors 59 Randomised Trial 59 IFN beta 59 Lung Cancer Trial 59 Olanzapine 59 Non Alcoholic Fatty 59 ertapenem 59 Lung Cancer Patients 59 Partial Onset Seizures 59 deep venous thromboses 59 candidemia 59 Anticancer Activity 59 Thrombin 59 Paraplatin ® 59 FDA Okays 59 Demonstrate Significant 59 Liver Failure 59 Invasive Breast Cancer 59 Pneumococcal Vaccine 59 3TC lamivudine Epivir 59 Cell Adhesion 59 anagrelide 59 Double Blind Placebo 59 Shows Promise Against 59 pharmacologically active isomer 59 interferon gamma 1b 59 Doxil ® 59 Neoadjuvant Chemotherapy 59 #mg/#mg 59 primidone 59 micafungin 59 Glucocorticoids 59 Abdominal Fat 59 Pramlintide 59 Leucovorin 59 HBeAg seroconversion 59 TPV r 59 CsA 59 Randomized Trials 59 Protelos 59 Thyroid Hormone 59 Progestin 59 Shows Statistically Significant 59 dual endothelin receptor antagonist 59 Ibritumomab Tiuxetan 59 Enlarged Prostate 59 boosted protease inhibitor 59 nanomolar 59 prednisone prednisolone 59 abdominal adiposity 59 Technosphere ® 59 intravesical therapy 59 Kinase Inhibitor 59 bezafibrate 59 Stent Restenosis 59 Squamous 59 alanine aminotransferase 59 irbesartan 59 inhaled budesonide 59 Danazol 59 Myocardial Ischemia 59 Completes Patient Enrollment 59 Postmenopausal 59 porcine derived 59 Invasive Fungal Infections 59 Peginterferon Alfa 2b 59 delafloxacin 59 virologic response 59 adefovir 59 serum calcium 59 Ziprasidone 59 K#N 59 Blood Flow 59 oral rivaroxaban 59 Drug Combo 59 Linezolid 59 Antidepressants Linked 59 NPH insulin 59 Immunogenic 59 Chemotherapeutic Agents 59 Apidra ® 59 Metastatic Pancreatic Cancer 59 serum urate levels 59 Telmisartan 59 TAXUS Stent 59 Infarct 59 serum urate 59 myeloperoxidase 59 D Dimer 59 indinavir 59 Cypher Sirolimus 59 Budesonide 59 Teva Provides Update 59 serum triglycerides 59 Gene Variants 59 Drug Prevents 59 Events MACE 59 Treprostinil 59 ULORIC 59 colorectal adenoma 59 homocysteine concentrations 59 biologic DMARD 59 tipranavir 59 Clinical Relevance 59 Receptor Agonist 59 Indacaterol 59 Myelodysplastic Syndrome MDS 59 Dalbavancin 59 Pivotal Phase III 59 divalproex sodium 59 Surgical Procedures 59 Antiretroviral Therapy 59 nucleoside analog 59 Adalimumab 59 tenofovir DF 59 Teriflunomide 59 Liposomal 59 ribavirin USP 59 leukotriene receptor antagonist 59 Subgroup Analysis 59 Eluting Stent 59 Mortgage Rates Remain 59 Intracerebral Hemorrhage 59 Drug Candidate 59 Cholesterol Drugs 59 INVEGA ® 59 RE LY ® 59 PRoFESS 59 symptomatic VTE 59 dose interleukin 59 Epratuzumab 59 dosing frequency 58 everolimus eluting stents 58 Predictive Value 58 Advanced Pancreatic Cancer 58 Immunogenicity 58 Treatment Reduces 58 Lupus Drug 58 Osteoporosis Drug 58 sargramostim 58 invasive aspergillosis 58 Amlodipine 58 Sulfonylurea 58 Oral Contraceptive 58 Blood Glucose Levels 58 antiepileptics 58 erlotinib Tarceva ® 58 Intubation 58 Ribavirin 58 Denufosol 58 Lung Function 58 Critically Ill Patients 58 liposomal amphotericin B 58 Epithelial Cell 58 enalapril 58 Sustained Release 58 Epilepsy Drug 58 Colorectal Cancer Patients 58 Prognostic Value 58 trimethoprim sulfamethoxazole 58 vecuronium 58 Sandostatin R 58 Versus Placebo 58 Diabetic Neuropathy 58 Coronary Disease 58 mixed hyperlipidemia 58 Aortic Valve 58 Intracranial Aneurysms 58 Sperm Count 58 intravascular hemolysis 58 rabeprazole 58 serum HBV DNA 58 Epirubicin 58 ARCOXIA 58 Cholesterol Linked 58 Microalbuminuria 58 Comorbidities 58 HCl capsules 58 AZT 3TC 58 R lenalidomide 58 Laryngeal Cancer 58 Prostate Biopsy 58 acarbose 58 triiodothyronine 58 Trial Evaluating 58 Potency 58 rilpivirine 58 Contraindications 58 symptomatic intracranial hemorrhage 58 Pharmacokinetics PK 58 intravenous dosing 58 GnRH agonists 58 argatroban 58 Oral Anticoagulant 58 Antipsychotics 58 myopathy rhabdomyolysis 58 Neuroprotective Effects 58 CXCR4 expression 58 Non Responders 58 Virus Infection 58 AEGR 58 colorectal liver metastases 58 dasatinib Sprycel 58 Iron Deficiency 58 Osteoporosis Treatment 58 platelet inhibition 58 antimicrobial prophylaxis 58 Fluticasone Propionate 58 Xelox 58 Insulin Therapy 58 Thrombolysis 58 Acute Pancreatitis 58 Metastatic Melanoma 58 angiotensin II receptor blockers 58 serum testosterone 58 alpha GAL 58 Thrombotic 58 NovoRapid 58 Pivotal Study 58 PKC# 58 adefovir dipivoxil 58 transgene expression 58 BANZEL 58 HIV HCV coinfected 58 Nymox NX 58 Salmeterol 58 Sleep Duration 58 daunorubicin 58 Esomeprazole 58 serum homocysteine 58 Copegus ribavirin 58 docetaxel Taxotere ® 58 serum phosphorous 58 low dose ritonavir 58 Toxicities 58 Bicalutamide 58 Drug Eluting Stents 58 Lung Injury 58 Gastrointestinal Stromal Tumors 58 Loading Dose 58 thalidomide Thalomid 58 As Reasonably Achievable 58 Long Term Survival 58 grade astrocytomas 58 systemic corticosteroids 58 cTnI 58 Toremifene 58 benazepril 58 lamivudine zidovudine 58 Lymphocytic 58 Cognitive Impairment 58 protease inhibitor PI 58 CCX# B 58 Carcinomas 58 fluvoxamine Luvox 58 rFVIIa 58 Androgen 58 serum calcium levels 58 VAPRISOL 58 Higher Doses 58 Colorectal Cancer Risk 58 melphalan prednisone 58 Liver Injury 58 Prostate Cancer Risk 58 Stress Incontinence 58 Ozarelix 58 Oxygen Levels 58 dose colchicine 58 hydroxymethyl coenzyme 58 hyperoxaluria 58 JAK2 V#F 58 Enzyme Replacement Therapy 58 infusional 58 Anemia Drug 58 clopidogrel Plavix 58 Intravenous Immunoglobulin 58 Artery Disease 58 Lanthanum Carbonate 58 PEG IFN 58 Maleate 58 Combination Clinical Trial 58 Coronary Arteries 58 Less Invasive 58 Drug Eluting 58 Inhalation Solution 58 Power Methodology Manual 58 Gonadotropin 58 Lowers Risk 58 autoantibody levels 58 Phase III Trials 58 Risedronate 58 Platelet Function 58 Cardiac Function 58 Mortality Risk 58 Phase III Trial 58 intracranial hemorrhage ICH 58 Randomized Double Blind Placebo 58 Stenting 58 idarubicin 58 Survival Rate 58 Prospective Multicenter 58 Intranasal 58 interferon alfa 2b 58 Antibiotic Use 58 hydroxocobalamin 58 Tocilizumab 58 vasodilators 58 mm Stent 58 Quetiapine 58 Completes Enrollment 58 moderate renal impairment 58 Temsirolimus 58 nizatidine 58 Depressive Symptoms 58 Extended Release 58 oral prodrug 58 SCH # 58 Hydroxyurea 58 Disease Modifying 58 denileukin diftitox 58 ritonavir boosted atazanavir 58 antithrombotic therapy 58 Hormone Replacement 58 Menstrual Pain 58 Renal Cell Cancer 58 nadolol 58 suppressive therapy 58 ZOLINZA 58 tazobactam 58 Genetic Variation 58 serum PSA 58 Peginterferon alfa 2b 58 LHRH agonist 58 lipoprotein Lp 58 blood phenylalanine Phe 58 ara C 58 Shows Promising 58 PASI scores 58 gefitinib Iressa 58 basiliximab 58 PSADT 58 Blood Pressure Lowering 58 Patient Outcomes 58 APTIVUS R 58 serum prostate 58 lumbar spine bone 58 d4T 58 Systolic Blood Pressure 58 Investigational Treatment 58 stavudine 58 MR Angiography 58 transdermal estradiol 58 carotid artery stenting 58 Estrogen Therapy 58 Phase III Pivotal Trial 58 Fewer Side Effects 58 Ritonavir 58 Initiates Clinical Trial 58 antiarrhythmic drug 58 Tumor Progression 58 Tesamorelin 58 PRN FDA Approves 58 Ovarian Cancer Risk 58 Truvada emtricitabine 58 pravastatin Pravachol 58 Ischaemic 58 ST Segment Elevation 58 Bloodstream Infections 58 Rosuvastatin 58 TO AVOID PREGNANCY WHILE 58 Prostate Cancer Patients 58 Adverse Event 58 Zoledronic acid 58 bioavailable testosterone 58 natriuretic peptides 58 urinary calcium excretion 58 induced macular edema 58 somatostatin analog 58 EFFEXOR XR 58 Myeloma Patients 58 lopinavir ritonavir 58 Virologic Response 58 myelodysplastic myeloproliferative diseases 58 SPRYCEL ® 58 candesartan cilexetil 58 Proton Pump Inhibitors 58 ABCB1 58 plasma lipid 58 T2DM 57 Folate Levels 57 Postmenopausal Osteoporosis 57 Treatment Naive 57 unfavorable cytogenetics 57 Transdermal Delivery 57 Surgical Treatment 57 steroid dexamethasone 57 Dexamethasone 57 amprenavir 57 Clolar ® 57 glycoprotein IIb IIIa inhibitors 57 intensity pulsed ultrasound 57 meropenem 57 Oritavancin 57 NNRTIs 57 Clinical Outcomes 57 plasminogen activator inhibitor 57 uricase 57 hematological parameters 57 Asthma Treatment 57 expressors 57 Atomoxetine 57 Heartburn Drugs 57 Inhaled Nitric Oxide 57 thromboprophylaxis 57 Phase 2b Clinical Trial 57 SGPT 57 Tigecycline 57 ACTOS ® 57 colesevelam HCl 57 Respiratory Infections 57 Aggressive Prostate Cancer 57 Chronic HCV 57 Prevent Stroke 57 potent CYP#A# inhibitors 57 Unstable Angina 57 laser therapy LLLT 57 sustained virologic response 57 Ischemic Stroke 57 inhibitor RG# 57 Bacteremia 57 Glufosfamide 57 zidovudine AZT 57 FUSILEV enhances 57 Hepatic 57 Prognostic Factors 57 certolizumab